6.1
Sustainability Score
NOVOZYMES
| Country | : Denmark  |
| Sector | : Pharma / Agricultural Biotech |
| Market Cap | : 15,995 (M€) |
Sustainability Score Distribution
Scoring overview
| Score (0-10) | Sector avg | Ranking out of 544 | |||
|---|---|---|---|---|---|
| Sustainability | 6.1 | 6.1 | 159 | ||
| Our approach is based on analytical items contributing to the E, the S and the G, that can be highlighted as sustainability precursors and can be combined in an intellectually acceptable way. | |||||
| Governance | 6.3 | 6.3 | 310 | ||
| Board independence? | Yes | ||||
| Splitting CEO and chairman roles? | No | ||||
| +10 other Governance metrics | |||||
| Social | 5.5 | 5.5 | 436 | ||
| Are accident at work declining? | No | ||||
| Wage dispersion trend vs peers | 2 / 10 | ||||
| +22 other Social metrics | |||||
| Environment | 5.8 | 5.8 | 237 | ||
| Emission or consumption per € of capital employed on :
► Energy ► CO2 emissions ► Waste ► Water withdrawal |
|||||
| ESG impact on target price | 1.4% |
1.4% | 121 | ||
Pharma / Agricultural Biotech
| Company | Sustainability | Ranking |
|---|---|---|
| NOVOZYMES |
6.1 | 159 |
Search for scores
Discover our metrics on 462 european stocks. Alphavalue's approach relies on 4 independent pillars which are all based on proprietary data and methodology.
Methodology
| Learn more on our methodology : | |
| Access for issuers : | |
| To AlphaValue research platform: |
Notice
The information provided is for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. Usage as a benchmark is not permitted. Unless otherwise explicitly agreed in writing, usage for products and services, index creation, derivative work, portfolio or fund management, or any other usage are not permitted. Usage is permitted to the related "rated" company mentioning AlphaValue as a source.